It is hard to overstate the medical importance and burden ofvector-transmitted infectious diseases. Whether the metric usedis mortality (malaria, for example, kills 1 million to 2 millionpeople annually, most of them children under 5 years of age),morbidity (more than 70 million years of healthy living arelost to malaria, Chagas' disease, leishmaniasis, dengue fever,lymphatic filariasis, and the encephalitis viruses), or somethingas difficult to quantify as anxiety in a population (activitiesin outdoor playgrounds and high schools, for example, were movedor suspended along the south shore of Massachusetts this pastfall because of concern . . . [Full Text of this Article]
Source Information
Dr. Klempner is a professor of medicine and microbiology and associate provost for research at Boston University School of Medicine, Boston, and an associate editor of the Journal. Dr. Unnasch is a professor at the Department of Global Health, College of Public Health, University of South Florida, Tampa. Dr. Hu is an associate professor of medicine at Tufts University School of Medicine, Boston.
This article has been cited by other articles:
Holloway, G. A., Charman, W. N., Fairlamb, A. H., Brun, R., Kaiser, M., Kostewicz, E., Novello, P. M., Parisot, J. P., Richardson, J., Street, I. P., Watson, K. G., Baell, J. B.
(2009). Trypanothione Reductase High-Throughput Screening Campaign Identifies Novel Classes of Inhibitors with Antiparasitic Activity. Antimicrob. Agents Chemother.
53: 2824-2833
[Abstract][Full Text]
(2007). Paromomycin: Another Option for Treating Leishmaniasis. JWatch Infect. Diseases
2007: 2-2
[Full Text]
Previous
Slide Presentation
